Fortress Biotech (FBIO) Cash & Equivalents Growth (3y) (2013 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -15.41% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 8.23% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 47.78% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -23.18% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 14.34% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 37.45% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -27.97% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -3.85% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 36.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.07% |
| Dec 31, 2025 | -23.64% |
| Sep 30, 2025 | -25.48% |
| Jun 30, 2025 | -33.13% |
| Mar 31, 2025 | -31.77% |
| Dec 31, 2024 | -42.79% |
| Sep 30, 2024 | -38.48% |
| Jun 30, 2024 | -34.81% |
| Mar 31, 2024 | -33.89% |
| Dec 31, 2023 | -29.74% |
| Sep 30, 2023 | -30.82% |
| Jun 30, 2023 | -24.77% |
| Mar 31, 2023 | 3.90% |
| Dec 31, 2022 | 9.21% |
| Sep 30, 2022 | 15.58% |
| Jun 30, 2022 | 18.52% |
| Mar 31, 2022 | 35.16% |
| Dec 31, 2021 | 67.12% |
| Sep 30, 2021 | 38.14% |
| Jun 30, 2021 | 40.76% |